News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
436,526 Results
Type
Article (26278)
Company Profile (123)
Press Release (410125)
Multimedia
Podcasts (58)
Webinars (10)
Section
Business (136701)
Career Advice (1194)
Deals (24676)
Drug Delivery (85)
Drug Development (56193)
Employer Resources (105)
FDA (9903)
Job Trends (9475)
News (232163)
Policy (21197)
Tag
Academia (1496)
Academic (1)
Accelerated approval (2)
Adcomms (9)
Allergies (58)
Alliances (34421)
ALS (64)
Alzheimer's disease (781)
Antibody-drug conjugate (ADC) (72)
Approvals (9931)
Artificial intelligence (172)
Autoimmune disease (16)
Automation (9)
Bankruptcy (208)
Best Places to Work (7161)
BIOSECURE Act (11)
Biosimilars (73)
Biotechnology (59)
Bladder cancer (43)
Brain cancer (20)
Breast cancer (161)
Cancer (1232)
Cardiovascular disease (122)
Career advice (1020)
Career pathing (22)
CAR-T (70)
Cell therapy (218)
Cervical cancer (12)
Clinical research (46771)
Collaboration (522)
Compensation (196)
Complete response letters (17)
COVID-19 (1702)
CRISPR (27)
C-suite (185)
Cystic fibrosis (66)
Data (1323)
Denatured (20)
Depression (20)
Diabetes (186)
Diagnostics (3318)
Digital health (5)
Diversity (5)
Diversity, equity & inclusion (31)
Drug discovery (88)
Drug pricing (82)
Drug shortages (26)
Duchenne muscular dystrophy (69)
Earnings (52214)
Editorial (32)
Employer branding (9)
Employer resources (96)
Events (60205)
Executive appointments (590)
FDA (10668)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (453)
Gene editing (61)
Generative AI (11)
Gene therapy (190)
GLP-1 (537)
Government (2466)
Grass and pollen (5)
Guidances (39)
Healthcare (9880)
Huntington's disease (11)
IgA nephropathy (21)
Immunology and inflammation (73)
Indications (19)
Infectious disease (1781)
Inflammatory bowel disease (104)
Inflation Reduction Act (7)
Influenza (29)
Intellectual property (73)
Interviews (178)
IPO (10110)
IRA (36)
Job creations (2612)
Job search strategy (908)
Kidney cancer (8)
Labor market (22)
Layoffs (269)
Leadership (11)
Legal (5147)
Liver cancer (43)
Lung cancer (156)
Lymphoma (91)
Machine learning (4)
Management (35)
Manufacturing (231)
MASH (57)
Medical device (6067)
Medtech (6071)
Mergers & acquisitions (14948)
Metabolic disorders (476)
Multiple sclerosis (64)
NASH (19)
Neurodegenerative disease (54)
Neuropsychiatric disorders (13)
Neuroscience (1130)
NextGen: Class of 2025 (3642)
Non-profit (2236)
Now hiring (10)
Obesity (252)
Opinion (166)
Ovarian cancer (41)
Pain (72)
Pancreatic cancer (40)
Parkinson's disease (88)
Partnered (12)
Patents (156)
Patient recruitment (64)
Peanut (25)
People (43662)
Pharmaceutical (68)
Pharmacy benefit managers (13)
Phase I (12723)
Phase II (20347)
Phase III (17080)
Pipeline (781)
Policy (105)
Postmarket research (1905)
Preclinical (5102)
Press Release (52)
Prostate cancer (76)
Psychedelics (19)
Radiopharmaceuticals (170)
Rare diseases (269)
Real estate (3814)
Recruiting (41)
Regulatory (14971)
Reports (26)
Research institute (1409)
Resumes & cover letters (151)
Rett syndrome (2)
RNA editing (2)
RSV (24)
Schizophrenia (53)
Series A (90)
Series B (45)
Service/supplier (6)
Sickle cell disease (42)
Special edition (9)
Spinal muscular atrophy (116)
Sponsored (14)
Startups (2546)
State (2)
Stomach cancer (7)
Supply chain (47)
Tariffs (34)
The Weekly (36)
Vaccines (448)
Venture capitalists (26)
Weight loss (165)
Women's health (22)
Worklife (10)
Date
Last 7 days (497)
Last 30 days (1450)
Last 365 days (19657)
2025 (6488)
2024 (21316)
2023 (24097)
2022 (32798)
2021 (34928)
2020 (33357)
2019 (27967)
2018 (21613)
2017 (22095)
2016 (21340)
2015 (25083)
2014 (19484)
2013 (16199)
2012 (17466)
2011 (18207)
2010 (16373)
Location
Africa (520)
Alabama (22)
Alaska (5)
Arizona (100)
Arkansas (5)
Asia (36063)
Australia (5219)
California (3178)
Canada (1375)
China (391)
Colorado (150)
Connecticut (130)
Delaware (86)
Europe (66059)
Florida (515)
Georgia (129)
Idaho (25)
Illinois (329)
India (23)
Indiana (232)
Iowa (2)
Japan (143)
Kansas (70)
Kentucky (16)
Louisiana (8)
Maine (18)
Maryland (523)
Massachusetts (2436)
Michigan (76)
Minnesota (197)
Missouri (41)
Montana (22)
Nebraska (15)
Nevada (32)
New Hampshire (24)
New Jersey (1210)
New Mexico (18)
New York (1011)
North Carolina (581)
North Dakota (2)
Northern California (1347)
Ohio (101)
Oklahoma (9)
Oregon (21)
Pennsylvania (766)
Puerto Rico (11)
Rhode Island (15)
South America (809)
South Carolina (10)
Southern California (1295)
Tennessee (53)
Texas (465)
United States (12783)
Utah (86)
Virginia (104)
Washington D.C. (39)
Washington State (281)
West Virginia (1)
Wisconsin (25)
436,526 Results for "sihuan pharmaceutical holdings group ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
Vanda Pharmaceuticals Inc. confirmed that it has received an unsolicited, non-binding indication of interest from Cycle Group Holdings Ltd. to acquire the Company for $8.00 per share in cash.
June 6, 2024
·
3 min read
Sihuan Pharmaceutical Was Selected As One Of The First Echelon Of Enterprises In The list of China’s Top 100 Pharmaceutical Innovative Enterprises in 2023
Sihuan Pharmaceutical Holdings Group Ltd. is pleased to announce that the “Group” was selected as one of the first echelon of enterprises in The list of China’s Top 100 Pharmaceutical Innovative Enterprises in 2023.
October 14, 2023
·
2 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.
October 15, 2024
·
3 min read
Press Releases
Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering
February 26, 2025
·
5 min read
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA
Sihuan Pharmaceutical Holdings Group Ltd. together with its subsidiaries, is pleased to announce that Xuanzhu Biopharmaceutical Co., Ltd., a non-wholly owned subsidiary of Company, has received a drug registration approval from the National Medical Products Administration of China of Anaprozole Sodium Enteric-coated Tablet for the treatment of duodenal ulcer.
June 27, 2023
·
5 min read
Press Releases
Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to “BGM”
August 13, 2024
·
2 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Sihuan Pharmaceutical（0460.HK）: Huisheng Biopharmaceutical Successfully Completed the A + Round of Financing
Sihuan Pharmaceutical Holdings Group Co., Ltd. is pleased to announce that the Group’s Jilin Huisheng Biopharmaceutical Co., Ltd., a non-wholly owned subsidiary, has successfully completed the acquisition of Jilin Baixing Bairong Investment Center *, JiLin Province Private Equity Co., Ltd., Jilin Province Technology Investment Fund Co., Ltd. in the A+ round of financing by way of capital increase.
January 4, 2023
·
3 min read
Press Releases
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
November 11, 2024
·
4 min read
1 of 43,653
Next
